Medical specialists from Portugal tagged as investigators in clinical trials studying Breast Neoplasms
Total 32 results
-
Adriana Novais Lopes Monteiro SoaresSeen in:
- Other, Vila Nova de Gaia, Centro Hospitalar De Vila Nova De Gaia Espinho
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Ângela Nogal DiasSeen in:
- Setúbal, Almada, Hopital Garcia de Orta
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Ângelo PassosSeen in:
- Lisboa, Clínica Dr. Passos Ângelo in Lisbon
Trials:- NCT06291896 (Principal Investigator)
Conditions: -
António L Palmeira, PhDSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Sub-Investigator)
-
Bruno Rodrigues, MScSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Sub-Investigator)
-
Carlos Carvalho, MDSeen in:
- Lisbon, Fundacao Champalimaud
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Carlos Mavioso, MDSeen in:
- Lisboa, Champalimaud Research and Clinical Centre, Champalimaud Foundation
Trials:- NCT05196269 (Sub-Investigator)
Conditions: -
Catarina PortelaSeen in:
- Other, Braga, Hospital de Braga
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Celeste AlvesSeen in:
- Lisboa, Champalimaud Foundation
Trials:- NCT06291896 (Principal Investigator)
Conditions: -
Cristiana MarquesSeen in:
- Porto, Vila Nova de Gaia, Centro Hospitalar de Vila Nova de Gaia/Espinho - Unidade I
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
David Pinto, MDSeen in:
- Lisboa, Champalimaud Research and Clinical Centre, Champalimaud Foundation
Trials:- NCT05196269 (Sub-Investigator)
Conditions: -
Fatima CardosoSeen in:
- Lisboa, Lisbon, Champalimaud Foundation
- Other, Lisbon, Champalimaud Clinical Center
Trials:- NCT05514054 (Principal Investigator)
- NCT05132582 (Principal Investigator)
Conditions: -
Flávio Jerónimo, MScSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Sub-Investigator)
-
Ines Brandao Rego, MDSeen in:
- Porto, Centro Hospitalar Universitario Sao Joao
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Inês Nobre, MScSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Sub-Investigator)
-
Joao GodinhoSeen in:
- Lisboa, Hospital da Luz Lisboa
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Manuela Fiuza, MD, PhDSeen in:
- Lisbon, Associação para Investigação e Desenvolvimento da Faculdade de Medicina
Trials:- NCT03297346 (Principal Investigator)
Conditions: -
Margarida Brito, MDSeen in:
- Lisbon, Hospital São Francisco Xavier
Trials:- NCT03111615 (Sub-Investigator)
Conditions: -
Maria Antónia VasconcelosSeen in:
- Lisboa, Champalimaud Foundation
Trials:- NCT06291896 (Sub-Investigator)
Conditions: -
Maria-Joao Cardoso, MD, PhDSeen in:
- Lisboa, Champalimaud Research and Clinical Centre, Champalimaud Foundation
Trials:- NCT05196269 (Principal Investigator)
Conditions: -
Marlene N Silva, PhDSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Principal Investigator)
-
Nuno Rato, MScSeen in:
- Porto, Gaia, Centro Hospitalar Vila Nova Gaia e Espinho
Trials:- NCT05976815 (Principal Investigator)
Conditions: -
Pedro Gouveia, MD, PhDSeen in:
- Lisboa, Champalimaud Research and Clinical Centre, Champalimaud Foundation
Trials:- NCT05196269 (Sub-Investigator)
Conditions: -
Pedro MadeiraSeen in:
- Other, Coimbra, Instituto Portugues de Oncologia de Coimbra Francisco Gentil, EPE (IPO, Coimbra)
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Pedro SimõesSeen in:
- Lisboa, Hospital Beatriz Angelo
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Rita Teixeira de SousaSeen in:
- Other, Lisboa, Hospital Santa Maria
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Rogelio Andrés-Luna, MDSeen in:
- Lisboa, Champalimaud Research and Clinical Centre, Champalimaud Foundation
Trials:- NCT05196269 (Sub-Investigator)
Conditions: -
Sofia BragaSeen in:
- Other, Lisboa, Hospital Cuf Descobertas
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Sofia Franco, MScSeen in:
- Lisboa, Universidade Lusófona, Campo Grande 376
Trials:- NCT05860621 (Sub-Investigator)
-
Sofia TorresSeen in:
- Lisboa, Lisbon, Centro Hospitalar Universitario Lisboa Norte, E.P.E. - Hospital de Santa Maria
Trials:- NCT05514054 (Principal Investigator)
Conditions:
Clinical Trials on Breast Neoplasms
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, MaleUnited States
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy